Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Referring to the announcement published on 25/10/2026 concerning the AGM minutes (before certification) held on 22/10/2026, the company sent a correction.
Correction from the Company (2,266 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Referring to the announcement published on 25/10/2026 concerning the AGM minutes (before certification) held on 22/10/2026, the company sent a correction.
Correction from the Company (2,266 KB)